Adaptimmune Therapeutics (ADAP)
NASDAQ: ADAP
· Real-Time Price · USD
0.28
-0.00 (-1.06%)
At close: Jun 09, 2025, 3:58 PM
Adaptimmune Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -69.92M | -70.81M | -44.49M | -72.47M | -163.38M | -113.87M | -95.2M | -91.02M | -114.16M | -165.46M | -175.06M | -176.04M | -170.59M | -158.09M | -155.84M | -148.88M | -139.69M |
Depreciation & Amortization | 10.66M | 11.2M | 11.26M | 11.34M | 10.83M | 9.84M | 8.41M | 7M | 6.33M | 6.08M | 6.87M | 6.83M | 6.73M | 6.57M | 6.06M | 6.43M | 7.14M |
Stock-Based Compensation | 7.55M | 9.99M | 10.23M | 10.36M | 13.2M | 11.77M | 12.64M | 13.12M | 14.33M | 18.24M | 19.12M | 20.48M | 20.88M | 20.63M | 18.86M | 17.13M | 14.3M |
Other Working Capital | -71.36M | -68.97M | -45.37M | -4.53M | 22.1M | -22.93M | -27.79M | -33.31M | -31.68M | -1.33M | 138.09M | 136.93M | 141.94M | 134.63M | -28.34M | -5.96M | -6.83M |
Other Non-Cash Items | 13.1M | 14.15M | 4.37M | 613.99K | -23.42M | -23.67M | -22.21M | -22.96M | -36K | 130K | -1.41M | 1.11M | 849K | 1.17M | -633K | 628K | 1.1M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.94M | 3.2M | 3.07M | 5.82M | 7.49M | 7.12M | 7M |
Change in Working Capital | -47.07M | -36.72M | -34.25M | 6.58M | 28.13M | -24.87M | -27.71M | -33.23M | -31.89M | -1.53M | 137.89M | 136.72M | 141.94M | 134.63M | -28.34M | -5.96M | -6.83M |
Operating Cash Flow | -155.25M | -120.59M | -101.06M | -91.77M | -135.53M | -140.88M | -124.16M | -127.16M | -124.65M | -141.77M | -9.88M | -6.92M | 2.87M | 10.73M | -152.41M | -123.53M | -116.99M |
Capital Expenditures | -2.36M | -2.72M | -2.38M | -2.23M | -2.72M | -4.88M | -7.48M | -17.43M | -25.15M | -29.74M | -30.35M | -21.79M | -14.61M | -8.78M | -5.97M | -5.11M | -3.85M |
Cash Acquisitions | n/a | n/a | -24.45K | -24.45K | 1.55K | 1.55K | -24.34M | -63.38M | -63.4M | -14.09M | 10.3M | 49.38M | 49.38M | 207K | 250K | 301K | 546K |
Purchase of Investments | -100.16M | -100.16M | -68.6M | -8.7M | -75.82M | -75.82M | -78.84M | -72.86M | -5.73M | -47.92M | -100.4M | -99.99M | -120.36M | -139.76M | -98.63M | -164.98M | -344.67M |
Sales Maturities Of Investments | 102.5M | 44.06M | 71.94M | 135.07M | 160.32M | 211.19M | 169.54M | 145.51M | 173.32M | 166.99M | 170.64M | 167.48M | 184.23M | 224.34M | 216.5M | 219.56M | 163.3M |
Other Investing Acitivies | -18.46M | -1.53M | -349.1K | -5.12K | 46.09M | 97.14M | 121.29M | 159.69M | 166.98M | 66.98M | 42.59M | 3.69M | -49.38M | -207K | -250K | -301K | -546K |
Investing Cash Flow | -17.44M | -58.95M | 1.28M | 124.61M | 128.05M | 176.74M | 129.29M | 100.84M | 142.25M | 89.14M | 39.69M | 45.69M | 49.26M | 75.8M | 111.9M | 49.47M | -185.22M |
Debt Repayment | 25M | 25M | 25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -939K | 24.58M | 24.65M | 24.81M | 322K | 256K | 191K | 36K | 23K | 50K | 94K | 217K | 260K | 759K | 829K | 1.17M | 5.3M |
Financial Cash Flow | 24.19M | 78.73M | 78.81M | 54.4M | 29.9M | 880K | 2.21M | 3.06M | 13.03M | 12.87M | 11.52M | 10.2M | 2.79M | 3.29M | 3.36M | 3.69M | 249.14M |
Net Cash Flow | -100.52M | -53.64M | 26.52M | 134.64M | 22.25M | 37.41M | 12.36M | -19.32M | 30.19M | -42.06M | 36.08M | 44.44M | 54.22M | 90.18M | -38.27M | -71.6M | -53.72M |
Free Cash Flow | -110.22M | -75.92M | -56.05M | -46.61M | -138.24M | -145.76M | -131.64M | -144.59M | -149.8M | -171.51M | -40.24M | -28.71M | -11.74M | 1.95M | -158.39M | -128.64M | -120.83M |